Pyrazinamide in elderly people-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pyrazinamide in elderly people

Published:2024-07-05 Issue: Volume: Page:
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Sandhu Avnish¹^ORCID,Kissner Dana²

Affiliation:

1. Wayne State University School of Medicine Department of Internal Medicine, Division of Infectious Diseases Detroit Michigan USA

2. Wayne State University School of Medicine Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine Detroit Michigan USA

Abstract

See related article

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/resp.14791

Reference10 articles.

1. World Health Organization.Global Tuberculosis Report 2023.https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023#:~:text=The%20World%20Health%20Organization%20Global the%20response%2C%20. Accessed 2024 Jun.

2. Tuberculosis in an Aging World

3. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis

4. The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis

5. RoussetS LafaurieM Guet‐RevilletH ProtinC GrusseJL DerumeauxH et al.Safety of pyrazinamide for the treatment of tuberculosis in older patients over 75 years of age: a retrospective monocentric cohort study.38(1):43–52.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP